Introducing Hydroxychloroquine Sulfate Tablets by PharmAlliance International Labs

Welcome to PharmAlliance International Labs, where our commitment to patient health and well-being drives our pursuit of excellence in pharmaceutical innovation. Our Hydroxychloroquine Sulfate Tablets stand as a testament to our dedication to providing reliable treatment options for a range of medical conditions, supported by rigorous manufacturing standards and a steadfast commitment to patient care.

Understanding the Drug Class:

Hydroxychloroquine sulfate belongs to the esteemed class of medications known as antimalarials and disease-modifying antirheumatic drugs (DMARDs). This versatile compound is widely utilized in the treatment of malaria, rheumatoid arthritis, and systemic lupus erythematosus (SLE), offering therapeutic benefits that extend far beyond its primary indication as an antimalarial agent.

Formulations and Dosage:

Our Hydroxychloroquine Sulfate Tablets are meticulously formulated to ensure optimal efficacy and patient compliance. Each tablet contains 200 mg of hydroxychloroquine sulfate, conveniently packaged in blister packs containing 30 tablets for easy dosing. Patients are advised to take the tablets orally with food or milk to minimize gastrointestinal discomfort, adhering to the prescribed dosage and duration of treatment as directed by their healthcare provider.

Indications and Usage:

Hydroxychloroquine Sulfate Tablets are indicated for the treatment and prophylaxis of malaria caused by various Plasmodium species, including P. vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. Additionally, they are prescribed for the management of rheumatoid arthritis and systemic lupus erythematosus (SLE), encompassing both acute and chronic forms of these autoimmune conditions.

Pharmacokinetics and Pharmacodynamics:

The pharmacokinetic profile of Hydroxychloroquine Sulfate is characterized by its efficient absorption from the gastrointestinal tract, with peak plasma concentrations achieved within 3 to 6 hours post-administration. This compound exhibits extensive tissue distribution, including vital organs such as the liver, spleen, kidney, and lung. Mechanistically, hydroxychloroquine is believed to exert its therapeutic effects by interfering with lysosomal function, antigen presentation, and cytokine production, although its precise mode of action remains the subject of ongoing research.

Side Effects and Safety Profile:

While Hydroxychloroquine Sulfate Tablets are generally well-tolerated, patients may experience mild gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal cramps. Other potential side effects include headache, dizziness, skin rashes, and changes in vision. Serious adverse effects, although rare, may include retinopathy, cardiomyopathy, and hematological disorders. Patients are advised to report any unusual symptoms or adverse reactions to their healthcare provider promptly.

Conclusion:

At PharmAlliance International Labs, we prioritize the safety, efficacy, and well-being of our patients above all else. Our Hydroxychloroquine Sulfate Tablets exemplify our unwavering commitment to delivering high-quality pharmaceutical products that make a meaningful difference in the lives of individuals worldwide. Trust in the reliability and efficacy of our Hydroxychloroquine Sulfate Tablets and embark on a journey towards improved health and vitality. For more information, please visit our website or consult your healthcare provider.